Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yamazaki

Showing results (121-130 of 252) with videos related to

Pageof 26
Sort By:
International Journal of Clinical Oncology|September 3, 2021
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancerHiroyuki Okuyama, Yoshinori Kagawa, Toshiki Masuishi, et al.
International Journal of Clinical Oncology|February 15, 2014
Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancerAkira Watanabe, Kentaro Yamazaki, Yusuke Kinugasa, et al.
American Journal of Veterinary Research|January 23, 2025
Evidence for successful gastric perfusion computed tomography with low-radiation doseKazuya Kushida, Mizuki Tamazawa, Miu Matsumoto, et al.
International Journal of Clinical Oncology|August 18, 2011
Leptomeningeal carcinomatosis associated with gastric cancerHideharu Tomita, Hirofumi Yasui, Narikazu Boku, et al.
Experimental Animals|December 4, 2024
Canine regional gastric blood flow measurement using perfusion computed tomographyKazuya Kushida, Miu Matsumoto, Mizuki Tamazawa, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2020
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancerYosuke Kito, Hironaga Satake, Hiroya Taniguchi, et al.
Anticancer Research|March 9, 2012
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Tetsuya Hamaguchi, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2009
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumorsNoboru Yamamoto, Tomohide Tamura, Nobuyuki Yamamoto, et al.
Japanese Journal of Clinical Oncology|February 3, 2007
The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancerKentaro Yamazaki, Narikazu Boku, Kaoru Shibamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2015
Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapyHiroyuki Tabuse, Hiroya Kashiwagi, Satoshi Hamauchi, et al.
Pageof 26

Showing results (121-130 of 252) with videos related to

Sort By:
Pageof 26
International Journal of Clinical Oncology|September 3, 2021
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancerHiroyuki Okuyama, Yoshinori Kagawa, Toshiki Masuishi, et al.
International Journal of Clinical Oncology|February 15, 2014
Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancerAkira Watanabe, Kentaro Yamazaki, Yusuke Kinugasa, et al.
American Journal of Veterinary Research|January 23, 2025
Evidence for successful gastric perfusion computed tomography with low-radiation doseKazuya Kushida, Mizuki Tamazawa, Miu Matsumoto, et al.
International Journal of Clinical Oncology|August 18, 2011
Leptomeningeal carcinomatosis associated with gastric cancerHideharu Tomita, Hirofumi Yasui, Narikazu Boku, et al.
Experimental Animals|December 4, 2024
Canine regional gastric blood flow measurement using perfusion computed tomographyKazuya Kushida, Miu Matsumoto, Mizuki Tamazawa, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2020
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancerYosuke Kito, Hironaga Satake, Hiroya Taniguchi, et al.
Anticancer Research|March 9, 2012
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Tetsuya Hamaguchi, et al.
Cancer Chemotherapy and Pharmacology|March 25, 2009
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumorsNoboru Yamamoto, Tomohide Tamura, Nobuyuki Yamamoto, et al.
Japanese Journal of Clinical Oncology|February 3, 2007
The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancerKentaro Yamazaki, Narikazu Boku, Kaoru Shibamoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2015
Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapyHiroyuki Tabuse, Hiroya Kashiwagi, Satoshi Hamauchi, et al.
Pageof 26